https://biotechmorning.com/news/sangamo-gene-therapy-fire-sale-ptc-lilly Biotech Morning en 2026-09-05T14:14:42.926Z The $161M Fire Sale That Ended a Gene Therapy Pioneer https://biotechmorning.com/news/autoimmune-car-t-safety-problem Biotech Morning en 2026-09-05T14:13:57.273Z Autoimmune CAR-T Has a Problem Nobody Wants to Talk About https://biotechmorning.com/news/pelacarsen-lp-a-horizon-trial-failure Biotech Morning en 2026-09-05T14:13:12.027Z The Biggest Heart Drug Bet in a Decade Just Went Bust https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-crisis-2 Biotech Morning en 2026-09-05T14:12:21.405Z America's Only Syphilis Drug for Pregnant Women Just Got Recalled https://biotechmorning.com/news/menarini-gan-lee-glp1-licensing-deal-europe Biotech Morning en 2026-09-05T14:11:40.922Z Italy's Biggest GLP-1 Bet Came From a Company You've Never Heard Of https://biotechmorning.com/news/sarepta-black-box-layoffs-stock-rally Biotech Morning en 2026-09-05T14:10:52.720Z Sarepta's Worst Week: A Black Box, 500 Pink Slips, and a 33% Stock Rally https://biotechmorning.com/news/blood-test-changed-breast-cancer-treatment Biotech Morning en 2026-09-05T14:10:06.062Z A Blood Test Just Changed How We Treat Breast Cancer https://biotechmorning.com/news/zorevunersen-dravet-syndrome-4-year-data Biotech Morning en 2026-09-04T14:18:33.667Z The Drug That Might Actually Rewire a Child's Brain https://biotechmorning.com/news/pfizer-sells-seagen-adc-12-million-medicus Biotech Morning en 2026-09-04T14:17:44.697Z Pfizer Just Sold a Cancer Drug for the Price of a Nice House https://biotechmorning.com/news/fda-tempo-pilot-ai-devices-before-authorization Biotech Morning en 2026-09-04T14:17:00.054Z The FDA Just Let AI Doctors See Patients Without a License https://biotechmorning.com/news/ivonescimab-beats-keytruda-overall-survival-lung-cancer Biotech Morning en 2026-09-04T14:16:11.246Z The Cancer Drug That Just Beat the World's Best-Selling Medicine https://biotechmorning.com/news/alexander-disease-first-treatment-zanvastro Biotech Morning en 2026-09-04T14:15:22.452Z The Disease That Had Zero Treatments Just Got Its First https://biotechmorning.com/news/abbvie-crashes-myeloma-party-etentamig-phase-3 Biotech Morning en 2026-09-04T14:14:40.845Z AbbVie Crashes the Myeloma Party Three Years Late. Was It Worth the Wait? https://biotechmorning.com/news/roche-ucn2-muscle-sparing-weight-loss Biotech Morning en 2026-09-04T14:13:52.866Z Roche's Secret Weapon for Weight Loss Might Actually Save Your Muscles https://biotechmorning.com/news/keytruda-biosimilar-cipla-qilu-deal Biotech Morning en 2026-09-04T14:13:06.001Z The $32 Billion Drug Just Got a Rival From an Unlikely Tag Team https://biotechmorning.com/news/psilocybin-prevents-chemo-nerve-pain-mice Biotech Morning en 2026-09-04T14:12:18.108Z A Single Dose of Magic Mushrooms Blocked Chemo Pain for 8 Months https://biotechmorning.com/news/kardigan-myokardia-400m-ipo-comeback Biotech Morning en 2026-09-04T14:11:27.337Z The MyoKardia Gang Just Pulled Off a $400M Comeback https://biotechmorning.com/news/novartis-autoimmune-car-t-deaths-pause Biotech Morning en 2026-09-04T14:10:39.781Z The Cancer Therapy That Killed Three People Who Didn't Have Cancer